Introduction
The v-abl oncogene, the transforming gene of Abelson murine leukemia virus, arose from a recombination event between the Moloney murine leukemia virus genome and a normal mou8e cellular gene, c-abl (Abelson and Rabstein, 1970; Goff et al., 1980) . The product of the v-abl gene is a 160 kd fusion protein, of which the N-terminal 235 amino acids are encoded by the retroviral gag gene while the remainder of the protein is encoded by c-abl-derived sequences. p160QeQ'y*u is N-myristoylated on the N-terminal glycine of gag, ha8 intrinsic tyrosine kinase activity, and can transform fibroblasts in vitro and pre-B lymphocytes both in vitro and in vivo (Scher and Siegler, 1975; Rosenberg et al., 1975; Rosenberg and Baltimore, 1976; Witte et al., 1980; Sefton et al., 1982) . The v-abl protein is one of a family of myristoylated cytoplasmic proteintyrosine kinases of which the 60 kd c-src gene product is the prototype; however, the v&l gene product is distinct from proteins of the sfc family in that it also contains an approximately 70 kd unique C-terminal domain.
The mechanism of transformation of cells by the v-abl protein or other members of its family is unknown. Tyrosine kinase activity is thought to be essential to the transform- ing ability because transformation is temperature-dependent in cells infected with an Abelson virus containing a temperature-sensitive mutation affecting tyrosine kinase activity (Rosenberg and Witte, 1988) . Despite extensive searches for potential substrates of transforming proteintyrosine kinases such as v-abl and v-src (Hunter and Cooper, 1988; Kamps et al., 1986; Bell et al., 1987) , no substrates critical for transformation or for normal function have been identified, nor is it known if the same sets of proteins are required for normal and oncogenic activities. Without the definition of physiologically relevant substrates, it has been difficult to assess whether the mechanism of oncogenic activation of cytoplasmic tyrosine kinases reflects a change in enzymatic activity (for example, increased V,, for a normal substrate) or whether activation results from a change in a nonenzymatic parameter such as interaction with another protein or subcellular localization. While studies comparing ~160~ with p15CP@ have suggested an increase in kinase activity coincident with oncogenic activation (Ponticelli et al., 1982) , no comparison of the subcellular localization of the v-abl and c-ablproteins has been possible because of the low abundance of the normal cellular protein.
Studies of the subcellular localization of the v-src gene product in transformed chicken fibroblasts have shown that a significant fraction is associated with the inner surface of the plasma membrane, with particular affinity for regions of cell-cell contact and adhesion plaques (Rohrschneider, 1979 (Rohrschneider, , 1980 for review, see Kruegel et al., 1983) , while a distinct fraction of p60v-s'c may be localized in juxtanuclear structures (Resh and Erickson, 1985) . The amino terminus of the sfc protein is also myristoylated (Schultz et al., 1985) , and mutants that lose the myristoylation site can no longer transform fibroblasts and are not membrane associated (Kamps et al., 1985; Buss et al., 1986) , suggesting that access to some critical membraneassociated substrate may be essential for the transformation of fibroblasts by this protein. In Abelson murine leukemia virus-transformed rat fibroblasts, the v-abl gene product is also found at the membrane and at sites of cell-cell and cell-substratum contact (Rohrschneider and Najita, 1984) .
The mouse homolog of the v-abl gene is denoted c-abl, and is transcribed into two major mRNA transcripts which differ at their 5' ends. These two transcripts arise from splicing of two distinct 5' exons, which are transcribed from separate promoters, to a set of common exons in the c-abl gene (Ben-Neriah et al., 1988) . The two transcripts produce two distinct products, types I and IV c-ablproteins (referred to as c-abl (I) and (IV), respectively), which differ only at their N-termini. The c-abl (IV) protein is myristoylated on the N-terminal glycine (Jackson and Baltimore, 1989) , while the c-abl (I) protein is predicted from its sequence not to be myristoylated. Simple overexpression of either type I or type IV protein via a retroviral expression system is insufficient for transformation of NIH 3T3 cells, but a deletion of 53 amino acids from an N-terminal region of the c-abl (IV) protein is sufficient to activate its transforming potential fully, both with respect to fibroblast and B lymphoid cell transformation in vitro, and leukemogenicity in vivo (Jackson and Baltimore, 1989; see Figure 1 ). Conservation of this domain among cytoplasmic tyrosine kinases, phospholipase C-II, and the v-c& transforming protein suggests that it is a regulatory domain (Stahl et al., 1988; Mayer et al., 1988; for review, see Pawson, 1989) .
We used indirect immunofluorescence to examine the subcellular localization of transforming and nontransforming Abelson protein variants expressed in NIH 3T3 cells. We found that the overexpressed c-abl (IV) protein is largely nuclear in location. Using a transient expressionlimmunofluorescence assay system in COS-1 cells, we mapped a nuclear localization signal in the type IV protein to the abCspecific region C-terminal to the tyrosine kinase domain. Deletion of the 53 amino acid N-terminal putative regulatory region of the c-abl (IV) protein results in the localization of the protein to the cytoplasm, along with activation of its transforming potential.
lmmunofluorescence
Shows the c-ebl (IV) Protein Is Nuclear The amount of endogenous c-abl protein in NIH 3T3 cells is insufficient for immunofluorescence to be observed (R. Van Etten, unpublished data). The mouse c-abl (IV) protein has been overexpressed approximately lo-fold in the cell line BETA, a derivative of NIH 3T3 cells stably transfected with a retroviral expression construct containing a full-length cDNA of c-abl (IV) (Jackson and Baltimore, 1989). Indirect immunofluorescence of BETA cells was performed using two different immune reagents directed against the C-terminus of the abl protein: affinity-purified rabbit polyclonal antisera (directed against pEX5, a bacterial fusion protein containing the C-terminus of abl (Konopka et al., 1984; see Experimental Procedures) or purified monoclonal antibody 24-21 (also directed against pEX5; Schiff-Maker et al., 1986) . A large fraction of the protein was found to be in the nucleus, the rest was localized diffusely throughout the cytoplasm at a low concentration, or concentrated at the plasma membrane (Figures 2A, 28, and 2E) . The specificity of the staining was shown by loss of immunofluorescence when the primary antibody was blocked by preincubation with purified C-terminal domain (pEX5) protein ( Figures 2C and 2F ), or when purified preimmune rabbit IgG at the same concentration was used as primary antibody ( Figure 2D ). Omission of primary antibody resulted in no detectable fluorescence (data not shown).
Examination of cells by confocal laser scanning microscopy (CLSM) allows one to section a cell optically and thereby eliminate contributions to fluorescence from structures outside the plane of focus (Brakenhoff et al., 1985) . This feature can reveal structural details that are not apparent with conventional fluorescence microscopy. In Figure 3A , a BETA cell stained with anti-C-terminal (pEX5) sera was scanned through a mid-nuclear level. The staining of cytoplasmic filamentous structures that are oriented longitudinally in the cell, reminiscent of F-actin "stress fibers:' is readily apparent. Double-labeling experiments with FITC-conjugated phalloidin, which preferentially stains F-actin, have confirmed that these structures are actin filaments (Ft. Van Etten, unpublished data). High power CLSM of the BETA cells showed that the nu- clear staining was relatively homogeneous throughout the Transforming abl Proteins Are Cytoplasmic nuclear matrix, sparing the nucleoli, but may exhibit a or Plasma Membrane Associated small amount of increased concentration at the nuclear N54 cells are NIH 3T3 fibroblasts that are productively inenvelope ( Figure 38 ). Quantitation of the fluorescence imfected with Abelson murine leukemia virus and which exage obtained from CLSM indicated that between 40% to press large amounts of the p16tY**&' protein. Indirect 60% of the type IV protein in the cell was nuclear (see Eximmunofluorescence of these cells showed the cytoplasm perimental Procedures).
stained diffusely at a relatively high level, with little or no nuclear staining; preimmune sera gave no staining (Figures 4A and 48) . The v-abl protein showed particularly high concentration at the plasma membrane and regions of cell-cell contact, in agreement with previous reports (Rohrschneider and Najita, 1964) . The cells were not stained if exposed to immune reagents without being permeabilized first, indicating that the v-abl protein was associated with the inner surface of the plasma membrane (data not shown). More detailed studies showed preferential association of some of the v-ah) protein with adhesion plaques and the Golgi apparatus (R. Van Etten, unpublished data) .
Indirect immunofluorescence of fibroblasts expressing AXB, the activating deletion mutant of c&l (IV) (see Figure l) , showed a pattern essentially identical to that seen with v-ah/ ( Figure 4C ), with the majority of the protein distributed throughout the cytoplasm, membrane, and regions of cell-cell contact, and no appreciable amount in the nucleus. Thus, a deletion of 53 amino acids, which serves to activate the transforming potential of the cab/ (IV) protein, is accompanied by a dramatic change in subcellular localization.
A common feature of pl60@@'&' and AXB is that each lacks N-terminal sequences of the c-abl (IV) protein that could be important in directing the localization of the protein. We examined the localization of an activated transforming mutant of c-abl, H2BFL, which differs from the wild-type protein by only a linker insertion mutation near the C-terminal border of the region deleted in the AXE protein, giving an insertion of four additional amino acids (see Figure 1 ). This mutant protein was also localized to the cytoplasm ( Figure 4E ), which suggests that cytoplasmic localization is an intrinsic property of activated forms of abl, and not simply the result of removing N-terminal sequences. To study the requirements for nuclear localization, we first investigated whether a transient expressionlimmunofluorescence system using replicating S/40-based vectors would reproduce the localization seen in fibroblast cell lines stably expressing the c-abl(IV) and AXB mutant proteins. The cab/ (IV) and AXB cONAs were cloned into the COS cell expression vector PJ3G (see Experimental Procedures), a replicating vector that directs expression under the control of the BV40 early region promoter, and were introduced into COB-1 cells by DEAE-dextran transfection. The cells were assayed by indirect immunofluorescence 46-60 hr after transfection. The majority of the c-abl (IV) protein was found in the nucleus, again sparing the nucleoli, with a minimum of cytoplasmic staining and some increased concentration at the plasma membrane ( Figure 6A ). Mock-transfected cells showed a very low level of background fluorescence (data not shown).
In contrast, the AXB protein was excluded from the nucleus (Figure 58 ). Many of the cells showed an increased concentration of AXB protein in the region of the cytoplasm closely associated with the nucleus; this "juxtanuclear" staining was not likely to be the result of "leakage" of the AXB protein out of the nucleus due to damage to the nucleus during fixation or staining because the fine structure of the nucleus appeared intact under phase microscopy, and the nucleus appeared intact after staining with the DNA-specific fluorochrome H22356 (data not shown). In addition to this "juxtanuclear" staining, the AXB protein was localized diffusely throughout the cytoplasm, with some apparent increased concentration at the cell membrane. In 10% to 20% of cells expressing the protein, (6): pl609sglrabl in cells fixed and permeablilzed with methanol and acetone. Primary antibody in (A) was a 1:l mixture of anti-pEX4 and anti-pEX5 sera (both directed against the abl C-terminus) at a 1:300 dilution. In (6) it was rabbit preimmune serum at a I:300 dilution. (C) and (D): deletion mutant AXB in cells fixed with paraformaldehyde and permeabilized with Triton X-100. Primary antibody in (C)was a 1:l mixture of antipEX4 and antipEX5 sera at a 1:200 dilution, In (D) it was rabbit preimmune serum at a 1:200 dilution. (E) and (F): linker insertion mutant HZBFL in ceils fixed and permeabilized with methanol and acetone. Primary antibody in (E) was monoclonal antibody 24-21 (directed against the abl C-terminus (pEX5)). In (F) it was monoclonal antibody 24-21 adsorbed with pEX5 fusion protein. Secondary antibody was rhodamine-conjugated donkey antirabbit IgG in (A), (6). (C). and (D), and rhodamine-conjugated goat anti-mouse IgG in (E) and (F). Bar = 10 Km.
the AX6 protein was also found in the nucleus (data not cleus in COS cells under certain circumstances. Such nushown); the significance of this finding is unknown, but clear staining was never found in any AXB-transformed may reflect the ability of the AX9 protein to enter the nu-NIH 3T3 fibroblasts. Thus, in most cells, the immunofluo- (Dingwall and Laskey, 1966) , and a number of nuclear proteins such as SV46 large T antigen contain specific sequences which function to direct nuclear localization (Kalderon et al., 1984; Richardson et al., 1966; Wychowski et al., 1988; Lyons et al., 1987; Burglin and De Robertis, 19s/; Dang and Lee, 1986) . Such sequences are typicaky short motifs of basic amino acids. Inspection of the cab/ (IV) amino acid sequence revealed a motif of five contiguous lysines between residues 624 and 628, and we constructed a series of truncation mutants to determine if this motif was required for nuclear localization ( Figure SA) . A series of 3' truncation mutants of the c-eb/ (IV) cDNA were generated, and the subcellular localization of the corresponding C-terminal truncated c-ah/ (IV) proteins was determined in the COS cell immunofluorescence assay system. Western btotting demonstrated that the mutant proteins were expressed to high levels in the COS cells and had the expected sizes (P Jackson, unpublished data).
While the truncated proteins encoded by mutants AXho and ANar retained nuclear localization ( Figures 6B and  6C) , the protein product of mutant ABcl showed a dramatiCaliy different localization, with little or no protein in the nucleus, and the majority of the protein located diffusely throughout the cytoplasm ( Figure 6D ). The sequence between the Bcl I and Nar I sites encodes 7 amino acids (Lee et al., 1985) most strikingly the pentaiysine motif ( Figure  6A ), which is similar to nuclear localization signals found in several viral and cellular proteins (Table 1) . A sitedirected mutant replacing the fm consecutive lysine residues of the full-length c-&r/ (IV) protein with five glutamines, Q5, was coMrMed and assayed in the COS cell system. Thtt mutant was atso deficient in nuclear iocalization ( Figure 6E ). demonstrating that the pentalysine motif is specificatfy required for n&ear iocaliin.
Confirmation of the localization of the C-terminal mutants of the c-&r/ (IV) protein in NIH 3T3 cells stab@ expressing these proteins is in progress.
We have shown that a large fraction of the c-&I (IV) protein is nuclear when ovmqmsd in NIH 3T3 cells. Nuclear bcafii is also seen when the type IV protein is expressed in ceffs of a different species (ME-1 cells) and is dependent on the presence of a canonical nuclear localization signal, whti has been mapped to a region unique to ab!, C-terminal of the tyrosine kinase domain. The nuclear localization signal (KKKKK) is similar to other such signal sequences previously identified in a variety of viral and cellular proteins. Activation of transforming ability of the type IV protein by a deletion or small insertion in an N-terminal regulatory region is also associated with a change in localization of the protein from the nucleus to the cytoplasm. These results raise two distinct issues: the normal role of the cab/protein and the mechanism of activation of transforming ability of the abl proteins.
Before discussing the significance of these observations, it is important to explore their limitations. First, detection of nontransforming ablproteins by immunofluorescence requires them to be overexpressed by at least lo-fold. Thus, it might be that the nuclear accumulation of c-abl(lV) is an artifact. This is unlikely because the overexpression is not extreme, the protein is too large for passive transport into the nucleus and thus is likely to require a signal for transport, and, most convincingly, has a weli- defined nuclear localization signal similar to known signals. Because the transforming variants of the abl proteins are, in general, expressed at a level two to five times that seen in the cells expressing the highest levels of c-ab/(IV) protein (Jackson and Baltimore, 1989), a second possibility is that the apparent changed distribution of the transforming AXB mutant might be artifactual. The increased level of expression might have overwhelmed the capacity of the nucleus for the protein, with the majority of the protein cytoplasmic as a result. However, this interpretation is unlikely for two reasons. Quantitation of the absolute amount of fluorescence in the nucleus of AXB cells by confocal laser scanning microscopy indicates that it is severalfold lower than the amount present in the nucleus of the c-abl (IV) overexpressers, suggesting that "saturation" of the nucleus with abl protein is not the reason for the predominantly cytoplasmic localization of the AXB protein. More importantly, the AXB protein behaves in a qualitatively different manner than c-abl (IV) in the COS cell assay, where both proteins are expressed to about the same level (data not shown). It should be emphasized, however, that the normal c-ab/(IV) protein is not wholly nuclear: our quantitation shows about half the protein to be nuclear and half to be at various places in the cytoplasm. Two very important unanswered questions are whether a given c-abl (IV) molecule can translocate between nu- The single amino acid code is utilized. Basic amino acid residues are underlined.
cleus and cytoplasm, and whether there is any difference between the nuclear and cytoplasmic forms of the protein, either in covalent structure or in interactions with other proteins. For example, the c-abl (IV) protein is predicted from its sequence to be myristoylated on the N-terminal glycine residue, and the protein is labeled in vivo with [3H]myristic acid with the same efficiency as the viral protein p160ses/v-Bb', but the absolute fraction of either protein that is myristoylated is unknown. Therefore, it is not known whether any of the nuclear c-abl (IV) protein is myristoylated.
The presence of the c-abl (IV) protein in the nucleus makes it the first known nuclear protein-tyrosine kinase. The insulin receptor has been reported to be translocated to the nucleus after insulin binding, but no visualization of the proteins has been reported (Podlecki et al., 1967) . The presence of the c-abl (IV) protein in the nucleus presumably reflects part of its role in signal transduction.
Although several transmembrane protein-tyrosine kinases are known receptors for polypeptide growth factors, and their effect on nuclear events associated with growth has been documented, no direct link to the nucleus for these receptors or any of the cytoplasmic tyrosine kinases has been observed. There are several candidates for possible nuclear substrates for the c-abl (IV) tyrosine kinase. Foulkes and co-workers found a small fraction of the v-abl protein to be nuclear in transformed murine fibroblasts, and they purified a distinct set of phosphotyrosinecontaining nuclear proteins in v-abl transformed cells, several of which preferentially bound to mouse DNA over E. coli DNA (Bell et al., 1967) . Although our data do not confirm the presence of nuclear v-abl, it is possible that some of these proteins may be targets for the c-abl (IV) kinase. The mammalian homolog of the fission yeast cdc2 gene product (~34) has been shown to be phosphorylated on tyrosine, and loss of phosphotyrosine is associated with assembly of p34 into a macromolecular complex and activation of intrinsic serine kinase activity, both of which are thought to be necessary for the G2 to M transition in the cell cycle (Draetta and Beach, 1966) . In this regard, it is interesting that the NIH 3T3 cells overexpressing the c-abl (IV) protein grow significantly more slowly than the parental 3T3 cells by a factor of 2.5 to 3.0 (Jackson and Baltimore, 1969; P Jackson, unpublished data). The murine cdc2 gene product is therefore another potential substrate for the type IV kinase. In this model, the predicted effect of overexpression of the type IV kinase would be hyperphosphorylation on tyrosine of the p34 protein, leading to slowing of growth.
The activating deletion in AXB as well as the four amino acid insertion in HPBFL act to cause the c-abl (IV) protein to be largely cytoplasmic rather than nuclear. These mutations thus abrogate the function of the nuclear localization signal, which remains intact in these proteins. While the respective roles of the AXB domain and the five lysines in determining nuclear localization and controlling transformation require additional analysis, two considerations suggest that they have independent functions. First, the specific region deleted from c-abl (IV) in the AXB mutant is a partially conserved domain related to the N-terminus of the c-src protein (denoted SH3 for src homology region 3; Figure 1 ; Jackson and Baltimore, 1969) and amino acid substitutions and deletions in the SH3 region of pGoc-a can activate transforming activity (Kato et al., 1966; Potts et al., 1966) . The SH3 region thus appears to be a negative regulatory domain within these proto-oncogene products, and mutations that abrogate the negative influence of this domain activate the inherent transforming ability of c-abl (IV) and c-s)%. Second, the AXB domain lacks any recognizable nuclear localization signal. Consistent with this is the behavior of the transforming mutant H2BFL, which has retained the SH3 domain but is cytoplasmically localized. This suggests that relocalization of these proteins is a direct consequence of mutations in SH3 that activate transforming ability, and is not due to disruption of a nuclear localization signal. Confirmation of the distinct functions of the AXB region and the pentalysine motif will come from an assessment of their ability to direct nuclear localization when fused to a heterologous reporter protein. It must also be determined whether mutations in the pentalysine motif do not simply activate the transforming ability of c-abl (IV), with relocalization as a consequence. Preliminary results indicate that neither the ABcl or the Q5 mutant of c-ab/(IV) are able to transform NIH 3T3 fibroblasts (P. Jackson, unpublished data). The c-abl (IV) protein remains nuclear in BETA cells that have been transformed with an activated v-Ha-ras gene, indicating that cytoplasmic localization is an intrinsic property of activated forms of abl protein, and is not simply a general consequence of the transformed state (unpublished data).
Experimental Procedures Calls and Cell Culture
The murine NIH 3T3 fibroblast lines BETA, N54, and AXE, stably expressing the abl proteins c-abl (IV), gag/v-ah/, and AXE, respectively, were constructed, characterized, and propagated as described (Jackson and Baltimore, 1989) . COS-1 cells were routinely maintained in Dulbeccds modified Eagle's medium with 10% inactivated fetal calf serum in a 10% COs incubator at 3pC.
Immune Reagents
Rabbit polyclonal antisera against the v-abl trpE bacterial fusion proteins pEX2, pEX4, and pEX5 were produced as described (Konopka et al., 1984) Briefly, a 1.1 kb Smal-BamHI fragment of the c-abl cDNA was cloned into the BamHl site of the pGEX-1 expression vector, and the correct translational reading frame confirmed by DNA sequencing.
The resulting 40 kd fusion protein was purified from lysates of E. coli by affinity chromatography on glutathioneagarose (Sigma), and was shown to contain pEX5 determinants by Western blotting with anti-pEX5 antisera or monoclonal antibody 24-21 (data not shown). For affinity purification of anti-pEX5 antisera, approximately 2 mg of pEX5 fusion protein was coupled to Affigel-10 agarose beads (Bio-Rad), adsorbed with anti-pEX5 serum at 4% for 12 hr, IgG not bound was washed off with phosphate-buffered saline (PBS), and IgG specifically bound to the column was eluted with 0.1 M glytine-HCI (pH 2.8). The eluate was immediately neutralized, pooled, and concentrated by centrifugation (Centricon, Amicon Corp.) Protein concentration was determined by Bio-Rad protein reagent, and purified antibody stored at 4OC. IgG was purified from preimmune serum by affinity chromatography on protein A-sepharose (Pharmacia) in a similar manner. Monoclonal antibody24-21 was produced in tissue culture supernatants by growing hybridoma cells in DMEM containing 15% IFS until a stationary phase was reached. Cells were removed by centrifugation at 5000 x g for 10 min, and the monoclonal antibody purified by affinity chromatography on a goat anti-mouse IgG/sepharose column (Cappelt) as described above.
lmmunofluomscence Cells were typically plated onto sterilized glass cover slips the night before at a density of approximately l-2 x 10" cells/ems. For some experiments, cover slips were treated with purified fibronectin at 20 @ml (a gift from Dr. R. Hynes, Dept. of Biology, MIT) or poly-L-lysine at 1 mglml (Sigma) for 1 hr prior to addition of medium and cells. Cover slips were rinsed in PBS and fixed by either absolute methanol for 5 min followed by acetone for 2 min. both at -2fPC, or by 3% paraformaldehyde in PBS for 20 min at room temperature.
Paraformaldehydefixed cells were quenched in 50 mM glycine (pH 8.0) for 10 min, then permeabilized by 0.5% Triton X-100 in PBS for 5 min at room temperature. All subsequent steps were carried out at room temperature. Cells were then blocked by 5% normal donkey serum or normal goat serum (Jackson Immunoresearch) for 30 min for experiments utilizing donkey or goat secondary antibodies, respectively. Primary antibody was used at a dilution of 1:iOO to 1:300 for crude rabbit antisera, at l-10 &ml for affinity-purified antisera or monoclonal antibody 24-21, and as undiluted tissue culture supernatant in the case of monoclonal antibody 1984. Where indicated, affinity-purified anti-pEX5 antisera or monoclonal antibody 24-21 were blocked with pEX5 fusion protein by incubation with a lo-fold molar excess of purified fusion protein for 30 min prior to application to cells. Incubation of primary antibody was for 45 min. followed by extensive washing in PBS. The appropriate secondary antibody was used at a 1:lOO dilution for 30 min, after which the cells were washed briefly with PBS and mounted with Fluoromount CO!% Cell l?ansfectlon Between 0.5 and 1.0 pg of CsCI-purified plasmid DNA was used to transfect monolayers of COS-1 cells at a density of 3 x 104 cells/cm2 growing on sterilized glass cover slips. Transfection was by a DEAEdextran protocol with 0.1 mM chloroquine treatment (Sompayrac and Danna, 1981; Luthman and Magnusson, 1983) . After 46-60 hr, medium was removed and the cells fixed with methanol and acetone, followed by indirect immunofluorescence as described above.
Constructlon of C-Terminal Tnrncatlon Mutents of c-sbl (IV)
The cDNA for cab/ type IV was constructed in vector pJ3Q provided by Jay Morgenstern (Whitehead Institute, MIT). Briefly, a 4.1 kb EcoRl to Hindlll fragment from vector pPLclV (Jackson and Baltimore, 1989) was blunted with the Klenow fragment of E. coli DNA polymerase I, fitted with BamHl linkers and ligated into the BamHl site in the vector polylinker. This p&mid pJ3clV was used for all subsequent constructions. Mutant pJ3clVANar was constructed by cutting pJ3clV at the unique Narl site in c-abl and at a Clal site in the vector polylinker 3' to the gene; these sites were blunted with Klenow fragment, and fitted with a Spel ICmer linker with termination codons in all three translation frames. Mutant pJ3clVABcl was constructed by growing pJ3clV in E. coli strain GM48, cutting the demethylated DNA with Bell. blunting with Klenow, adding Spel 14mers, and religeting. The mutant pJ3clVQ5 was constructed by synthesizing both strands of a fragment spanning the Bell and Narl sites (changing each of the @sine codons to glutamine codons), and ligating the annealed oligonucleotides directly into the pJ3clV cut with Bell and Narl. Mutants were rescreened using the mutant oligonucleotides and verified by sequencing.
Construction
of Linker Insertion Mutant H2BFL
Mutant pPLH2B was generated by opening vector pPLclV (a retroviral expression construct of cab/ [IV); Jackson and Baltimore, 1989) at the 5' Hincll site and adding a BamHl 12-mer synthetic oligonucleotide linker (New England Biolabs) with the sequence pCGC GGA TCC GCG-OH, thus inserting the tetrapeptide RGSA between residues V138 and N139. Diane Casey, Mark Chafel, and Yoav Henis for assistance with immunofluorescence and microscopy; Xiao-Fan Wang and Dan Silver for gifts of COS-1 cells; Michael Paskind for DNA sequencing;
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